Skip to main content
OpenTrials

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Completed

Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia

NCT03109093

Conditions
ALL, Recurrent, Adult, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University Hospital of Frankfurt (Main) Frankfurt am Main, Hesse, Germany
  • Charité - Campus Benjamin Franklin Berlin, Germany
  • Uniklinik Dresden Dresden, Germany
  • Uniklinik Düsseldorf Düsseldorf, Germany
View all 22 locations
View Trial Details
Completed

Multiple Myeloma Minimal Residual Disease

NCT02627261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hôpital Huriez Lille, France
  • Centre Hospitalier Universitaire Hôtel-Dieu de Nantes Nantes, France
  • Centre Hospitalier Lyon Sud Pierre Bénité, France
View Trial Details
Completed

MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate

NCT02067143

Conditions
De Novo, Low-dose Corticosteroids Pretreatment, Neoplasm Metastasis, +7 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • Az.Ospedaliera S.G.Moscati Avellino, Italy
View all 61 locations
View Trial Details

Related conditions